| 注册
首页|期刊导航|山东医药|利拉鲁肽对糖耐量异常大鼠血清炎症指标的影响

利拉鲁肽对糖耐量异常大鼠血清炎症指标的影响

郭南京 孙嘉 湛奕 陈宏 张桦 蔡德鸿

山东医药2012,Vol.52Issue(17):7-9,3.
山东医药2012,Vol.52Issue(17):7-9,3.

利拉鲁肽对糖耐量异常大鼠血清炎症指标的影响

Effect of liraglutide on the serum inflammatory markers in impaired glucose tolerance OLETF rats

郭南京 1孙嘉 1湛奕 1陈宏 1张桦 1蔡德鸿1

作者信息

  • 1. 南方医科大学珠江医院,广州510282
  • 折叠

摘要

Abstract

Objective To investigate the effect of liraglutide on the serum inflammatory markers in impaired glucose tolerance OLETF (IGT-OLETF) rate. Methods A total of 29 IGT-OLETF rats were randomly divided into four groups. They were treated with a single intraperitoneal injection of either saline vehicle (NS group, n = 8) or liraglutide ( 50 )μg/kg group, n = 8; 100 μg/kg group, n=6; or 200 μg/kg group, n = 7; respectively) twice daily for 12 weeks. Eight LETO rats received saline vehicle intraperitoneal injection twice daily for 12 weeks and served as the normal control group. After 12-week intervention, blood glucose, islet cell function and insulin sensitivity (including: fasting blood glucose, insulin, insulin sensitivity index, insulin resistance index and islet beta cell function), and inflammatory markers (including: IL-6, high-sensitivity C-reactive protein, plasminogen activator inhibitor-1 and fibrinogen) were measured. Results Compared with the NS group, the blood glucose, islet cell function and insulin sensitivity were significantly improved and the serum inflammatory markers were significantly decreased in liraglutide-treated group (all P <0.05). Conclusions Liraglutide has anti-inflammatory effect, can improve islet cell function and insulin sensitivity, and decreases theserum inflammation markers in IGT-OLETF rats, which has the potential role to prevent diabetes and cardioascular disease.

关键词

糖尿病/糖耐量异常/利拉鲁肽/炎症指标/大鼠

Key words

diabetes, mellitus/ impaired glucose tolerance/ liraglutide/ inflammatory markers/ rats

分类

医药卫生

引用本文复制引用

郭南京,孙嘉,湛奕,陈宏,张桦,蔡德鸿..利拉鲁肽对糖耐量异常大鼠血清炎症指标的影响[J].山东医药,2012,52(17):7-9,3.

基金项目

中华国际医学交流基金会β-cell Academy研究资助项目(2100325) (2100325)

广东省医学科研技术研究基金资助项目(B2011207). (B2011207)

山东医药

OACSTPCD

1002-266X

访问量0
|
下载量0
段落导航相关论文